Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy
- PMID: 36624324
- DOI: 10.1007/s11605-022-05577-6
Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy
Abstract
Background: Although hypertension requiring medication (HTNm) is a well-known cardiovascular comorbidity, its association with postoperative outcomes is understudied. This study aimed to evaluate whether preoperative HTNm is independently associated with specific complications after pancreaticoduodenectomy.
Study design: Adults undergoing elective pancreaticoduodenectomy were included from the 2014-2019 NSQIP-targeted pancreatectomy dataset. Multivariable regression models compared outcomes between patients with and without HTNm. Endpoints included significant complications, any complication, unplanned readmissions, length of stay (LOS), clinically relevant postoperative pancreatic fistula (CR-POPF), and cardiovascular and renal complications. A subgroup analysis excluded patients with diabetes, heart failure, chronic obstructive pulmonary disease, estimated glomerular filtration rate from serum creatinine (eGFRCr) < 60 ml/min per 1.73 m2, bleeding disorder, or steroid use.
Results: Among 14,806 patients, 52% had HTNm. HTNm was more common among older male patients with obesity, diabetes, congestive heart failure, chronic obstructive pulmonary disease, functional dependency, hard pancreatic glands, and cancer. After adjusting for demographics, preoperative comorbidities, and laboratory values, HTNm was independently associated with higher odds of significant complications (aOR 1.12, p = 0.020), any complication (aOR 1.11, p = 0.030), cardiovascular (aOR 1.78, p = 0.002) and renal (aOR 1.60, p = 0.020) complications, and unplanned readmissions (aOR 1.14, p = 0.040). In a subgroup analysis of patients without major preoperative comorbidity, HTNm remained associated with higher odds of significant complications (aOR 1.14, p = 0.030) and cardiovascular complications (aOR 1.76, p = 0.033).
Conclusions: HTNm is independently associated with cardiovascular and renal complications after pancreaticoduodenectomy and may need to be considered in preoperative risk stratification. Future studies are necessary to explore associations among underlying hypertension, specific antihypertensive medications, and postoperative outcomes to investigate potential risk mitigation strategies.
Keywords: Antihypertensive medication; Hypertension; NSQIP; Pancreaticoduodenectomy; Postoperative outcomes; Whipple procedure.
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
References
-
- Jakhmola CK, Kumar A. Whipple’s pancreaticoduodenectomy: Outcomes at a tertiary care hospital. Med J Armed Forces India. 2014;70(4):321-326. https://doi.org/10.1016/j.mjafi.2014.08.011 - DOI - PubMed - PMC
-
- Greenblatt DY, Kelly KJ, Rajamanickam V, et al. Preoperative Factors Predict Perioperative Morbidity and Mortality After Pancreaticoduodenectomy. Ann Surg Oncol. 2011;18(8):2126-2135. https://doi.org/10.1245/s10434-011-1594-6 - DOI - PubMed
-
- House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative Predictors for Complications after Pancreaticoduodenectomy: Impact of BMI and Body Fat Distribution. J Gastrointest Surg. 2008;12(2):270-278. https://doi.org/10.1007/s11605-007-0421-7 - DOI - PubMed
-
- American College of Surgeons, National Surgical Quality Improvement Program (NSQIP) Surgical Risk Calculator. https://riskcalculator.facs.org/RiskCalculator/ . Accessed 14 Apr 2022
-
- User Guide for the 2019 ACS NSQIP Participant Use Data File (PUF). American College of Surgeons, National Surgical Quality Improvement Program; 2020. https://www.facs.org/-/media/files/quality-programs/nsqip/nsqip_puf_user... . Accessed 14 Apr 2022
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical